本團隊也將治療經驗及成果整理發表於國內外知名學術研討會及重量級國際期刊上，如台灣兒科醫學會年度學術演講研討會、歐洲臨床微生物及感染病學會年會(ECCMID2023、ECCMID 2024)、美國感染疾病醫學會(IDweek 2024)及影響因子大於5分的國際期刊。並持續整理COVID-19相關資料，繼續發表，與國內外分享處置COVID-19經驗。除積極進行COVID-19臨床研究外，也努力探究COVID-19基礎研究。共計發表國際論文30篇，國際研討會論文5篇，台灣兒科醫學會年會11篇。

1. 新冠病毒感染時期流行病學研究
Hsu, Y. L.(許玉龍), Lin, H. C.(林曉娟), Wei, H. M.(衛琇玫), Lai, H. C.(賴奐丞), & Hwang, K. P.(黃高彬) (2020). Temperature and the difference in impact of SARS CoV-2 infection (COVID-19) between tropical and non-tropical regions in Taiwan. Travel medicine and infectious disease, 36, 101790. (IF:20.44)
Hsu, Y. L.(許玉龍), Lin, H. C.(林曉娟), Wei, H. M.(衛琇玫), Lai, H. C.(賴奐丞), & Hwang, K. P.(黃高彬) (2020). One benefit of COVID-19 measures in Taiwan: The reduction of influenza infections and severe complications. Influenza and other respiratory viruses, 14(6), 757–758. (IF:5.606)
Chiu, Y. T. (邱玉婷), Tien, N., Lin, H. C.(林曉娟), Wei, H. M.(衛琇玫), Lai, H. C.(賴奐丞), Chen, J. A.(陳俊安), Low, Y. Y.(劉衍怡), Lin, H. H., Hsu, Y. L.(許玉龍), & Hwang, K. P.(黃高彬) (2022). Detection of respiratory pathogens by application of multiplex PCR panel during early period of COVID-19 pandemic in a tertiary hospital in Central Taiwan. Journal of microbiology, immunology, and infection, 55(6 Pt 2), 1144–1150. (IF:10.273)
Hsih, W. H., Cheng, M. Y., Ho, M. W., Chou, C. H., Lin, P. C., Chi, C. Y., Liao, W. C., Chen, C. Y., Leong, L. Y., Tien, N., Lai, H. C. (賴奐丞), Lai, Y. C., & Lu, M. C. (2020). Featuring COVID-19 cases via screening symptomatic patients with epidemiologic link during flu season in a medical center of central Taiwan. Journal of microbiology, immunology, and infection, 53(3), 459–466. (IF:10.273)

2. 新冠疫苗研發與應用研究
Hsieh, S. M., Liu, M. C., Chen, Y. H., Lee, W. S., Hwang, S. J., Cheng, S. H., Ko, W. C., Hwang, K. P.(黃高彬), Wang, N. C., Lee, Y. L., Lin, Y. L., Shih, S. R., Huang, C. G., Liao, C. C., Liang, J. J., Chang, C. S., Chen, C., Lien, C. E., Tai, I. C., & Lin, T. Y. (2021). Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan. The Lancet. Respiratory medicine, 9(12), 1396–1406. (IF: 102.64)
Wang, C. Y., Hwang, K. P. (黃高彬), Kuo, H. K., Peng, W. J., Shen, Y. H., Kuo, B. S., Huang, J. H., Liu, H., Ho, Y. H., Lin, F., Ding, S., Liu, Z., Wu, H. T., Huang, C. T., Lee, Y. J., Liu, M. C., Yang, Y. C., Lu, P. L., Tsai, H. C., Lee, C. H., … Monath, T. P. (2022). A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants. The Journal of clinical investigation, 132(10), e157707. (IF: 15.9)
Solante, R., Alvarez-Moreno, C., Burhan, E., Chariyalertsak, S., Chiu, N. C., Chuenkitmongkol, S., Do-Van, D., Hwang, K. P. (黃高彬), Kiertiburanakul, S., Lee, P. I., Lobo, R. C., Macias, A., Nghia, C. H., Ong-Lim, A., Ortiz Ibarra, J., Richtmann, R., Rodriguez-Morales, A. J., Safadi, M. A. P., & Satari, H. I. (2022). Further implications on the global real-world vaccine effectiveness against SARS-CoV-2. Expert review of vaccines, 21(9), 1355–1357. (IF: 5.683)
Solante, R., Alvarez-Moreno, C., Burhan, E., Chariyalertsak, S., Chiu, N. C., Chuenkitmongkol, S., Dung, D. V., Hwang, K. P. (黃高彬), Ortiz Ibarra, J., Kiertiburanakul, S., Kulkarni, P. S., Lee, C., Lee, P. I., Lobo, R. C., Macias, A., Nghia, C. H., Ong-Lim, A. L., Rodriguez-Morales, A. J., Richtmann, R., Safadi, M. A. P., … Thwaites, G. (2023). Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic. Expert review of vaccines, 22(1), 1–16. (IF: 5.683)
Wang, C. Y., Peng, W. J., Kuo, B. S., Ho, Y. H., Wang, M. S., Yang, Y. T., Chang, P. Y., Shen, Y. H., & Hwang, K. P. (黃高彬) (2023). Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses. PLoS pathogens, 19(4), e1010870. (IF: 7.464)

3. 兒童急性新冠感染研究
Lai, H. C.(賴奐丞), Hsu, Y. L.(許玉龍), Lin, C. H.(林曉娟), Wei, H. M.(衛琇玫), Chen, J. A.(陳俊安), Low, Y. Y.(劉衍怡), Chiu, Y. T.(邱玉婷), Lin, H. C.(林曉娟), & Hwang, K. P.(黃高彬) (2023). Bacterial coinfections in hospitalized children with COVID-19 during the SARS-CoV-2 Omicron BA.2 variant pandemic in Taiwan. Frontiers in medicine, 10, 1178041. (IF: 5.058)

4. 新冠感染臨床指引
Wu, H. Y., Chang, P. H., Chen, K. Y., Lin, I. F., Hsih, W. H., Tsai, W. L., Chen, J. A. (陳俊安), Lee, S. S., & GREAT working group (2022). Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment. Journal of microbiology, immunology, and infection, 55(6 Pt 1), 985–992. (IF:10.273)
Wu, H. Y., Chang, P. H., Huang, Y. S., Tsai, C. S., Chen, K. Y., Lin, I. F., Hsih, W. H., Tsai, W. L., Chen, J. A.(陳俊安), Yang, T. L., Lee, C. Y., Ho, T. S., Wang, H. W., Huang, S. F., Wu, A. Y., Chen, H. J., Chen, Y. C., Chen, W. C., Tseng, C. H., Lin, P. C., … 7th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group (2023). Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan. Journal of microbiology, immunology, and infection, 56(2), 207–235. (IF:10.273)

5. 新冠病毒機轉研究
Hsieh, M. H., Beirag, N., Murugaiah, V., Chou, Y. C., Kuo, W. S., Kao, H. F., Madan, T., Kishore, U., & Wang, J. Y. (王志堯) (2021). Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles. Frontiers in immunology, 12, 641360. (IF:8.787)

6. 兒童後新冠症候群研究
Hsu, Y. L. (許玉龍), Chen, P. C., Tsai, Y. F., Wei, C. H., Wu, L. S., Hsieh, K. S., Hsieh, M. H., Lai, H. C., Lin, C. H., Lin, H. C., Chen, C. H., Chen, A. C., Lin, H. C., Chou, I. C., Soong, W. J., Hwang, K. P., Lu, H. H., Pawankar, R., Tsai, H. J., & Wang, J. Y. (2024). Clinical Features and Vaccination Effects among Children with Post-Acute Sequelae of COVID-19 in Taiwan. Vaccines, 12(8), 910. (IF:5.2)
中台灣兒童後新冠之臨床表現，2023臺灣兒科醫學會第二五四屆學術演講會，臺北國際會議中心，2023.04.22~2023.04.23
後新冠症候群對於未成年族群是否有心臟血管的影響，2024臺灣兒科醫學會第二五八屆學術演講會，臺北國際會議中心，2024.04.20~2023.04.21
臺灣兒童後新冠患者的心理評估研究，2024臺灣兒科醫學會第二五八屆學術演講會，臺北國際會議中心，2024.04.20~2023.04.21
新冠肺炎後是否會增加過敏性疾病發生的機率-以美國電子病歷資料庫探勘結果，2024臺灣兒科醫學會第二五八屆學術演講會，臺北國際會議中心，2024.04.20~2023.04.21
兒童多樣化後新冠症狀與腸道微菌叢的相關性研究，2024臺灣兒科醫學會第二五八屆學術演講會，臺北國際會議中心，2024.04.20~2023.04.21
使用吸入型類固醇氣喘病患與COVID-19醫療使用之相關研究，2024臺灣兒科醫學會第二五八屆學術演講會，臺北國際會議中心，2024.04.20~2023.04.21
維生素D與兒童新冠感染後遺症的相關性研究，2024臺灣兒科醫學會第二五八屆學術演講會，臺北國際會議中心，2024.04.20~2023.04.21
兒童SARS-CoV-2感染住院患者的後新冠症候群：臨床特點及風險評估，2024臺灣兒科醫學會第二五八屆學術演講會，臺北國際會議中心，2024.04.20~2023.04.21
兒童後新冠症候群使用傳統中醫的臨床特色：回顧性觀察研究，2024臺灣兒科醫學會第二五八屆學術演講會，臺北國際會議中心，2024.04.20~2023.04.21
Different clinical presentations of post COVID-19 conditions between vaccinated and unvaccinated children after SARS-CoV-2 Omicron variant infection in Taiwan, ECCMID 2023 Denmark, Yu-Lung HSU, Hsiao-Chuan LIN, Huan-Cheng LAI, Chien-Heng LIN, Chieh-Ho CHEN, Hsiu-Mei WEI, An-Chyi CHEN, Hung-Chih LIN, I-Ching CHOU, Wen-Jue SOONG, Kao-Pin HWANG, Kai-Sheng HSIEH, Jiu-Yao WANG
The role of Epstein-Barr virus in children with post-acute sequelae of SARS-CoV-2 infection in Taiwan, ECCMID 2024 Spain, Yu-Lung Hsu, Pei-Chi Chen, Shi-Hsin Lawrence Wu, Kai-Sheng Hsieh, Huan-Cheng Lai, Hsiao-Chuan Lin, Kao-Pin Hwang, Jiu-Yao Wang
Significant Positive Correlation of PD-1 and PD-L1 Levels in Children with Post-acute Sequelae of SARS-CoV-2 Infection in Taiwan, IDWeek 2024 USA, Yu-Lung Hsu, Pei-Chi Chen, Shi-Hsin Lawrence Wu, Kai-Sheng Hsieh, Huan-Cheng Lai, Hsiao-Chuan Lin, Kao-Pin Hwang, Jiu-Yao Wang